These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11254580)

  • 1. Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses.
    Quin SJ; Langhorne J
    Infect Immun; 2001 Apr; 69(4):2245-51. PubMed ID: 11254580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
    Burns JM; Flaherty PR; Nanavati P; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells.
    D'Império Lima MR; Alvarez JM; Furtado GC; Kipnis TL; Coutinho A; Minóprio P
    Scand J Immunol; 1996 Mar; 43(3):263-70. PubMed ID: 8602459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice.
    von der Weid T; Kopf M; Köhler G; Langhorne J
    Eur J Immunol; 1994 Oct; 24(10):2285-93. PubMed ID: 7925557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL; Daly TM; Long CA
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi.
    Cheesman S; Tanabe K; Sawai H; O'Mahony E; Carter R
    Infect Genet Evol; 2009 Mar; 9(2):248-55. PubMed ID: 19121414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
    Taylor-Robinson AW; Smith EC
    Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
    Amante FH; Crewther PE; Anders RF; Good MF
    J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low CD4(+) T cell responses to the C-terminal region of the malaria merozoite surface protein-1 may be attributed to processing within distinct MHC class II pathways.
    Quin SJ; Seixas EM; Cross CA; Berg M; Lindo V; Stockinger B; Langhorne J
    Eur J Immunol; 2001 Jan; 31(1):72-81. PubMed ID: 11169440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium chabaudi AS: distinct CD4(+)CD25(+)Foxp3(+) regulatory T cell responses during infection in DBA/2 and BALB/c mice.
    Wang GG; Chen G; Feng H; Liu J; Jiang YJ; Shang H; Cao YM
    Parasitol Int; 2013 Feb; 62(1):24-31. PubMed ID: 22971347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.
    Taylor PR; Seixas E; Walport MJ; Langhorne J; Botto M
    Infect Immun; 2001 Jun; 69(6):3853-9. PubMed ID: 11349051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium chabaudi chabaudi (AS): differential cellular responses to infection in resistant and susceptible mice.
    Seixas E; Ostler D
    Exp Parasitol; 2005 Aug; 110(4):394-405. PubMed ID: 15953500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the polyclonal activation induced by Plasmodium chabaudi on ongoing OVA-specific B- and T-cell responses.
    Sardinha LR; D'Império Lima MR; Alvarez JM
    Scand J Immunol; 2002 Oct; 56(4):408-16. PubMed ID: 12234262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal.
    Shuaibu MN; Cherif MS; Kurosaki T; Helegbe GK; Kikuchi M; Yanagi T; Sasaki H; Hirayama K
    Vaccine; 2011 Apr; 29(17):3239-47. PubMed ID: 21354479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
    Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
    Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific antibodies against Plasmodium falciparum antigens in immune subjects: II. Screening of responses against the merozoite major surface antigen (MSP!)].
    Nguer CM; Diouf A; Diallo TO; Dieye A; Tall A; Diouf B; Molez JF; Trape JF; Perraut R; Garraud O
    Dakar Med; 1997; 42(2):106-10. PubMed ID: 9827130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells.
    Opata MM; Carpio VH; Ibitokou SA; Dillon BE; Obiero JM; Stephens R
    J Immunol; 2015 Jun; 194(11):5346-54. PubMed ID: 25911759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance.
    Stephens R; Albano FR; Quin S; Pascal BJ; Harrison V; Stockinger B; Kioussis D; Weltzien HU; Langhorne J
    Blood; 2005 Sep; 106(5):1676-84. PubMed ID: 15890689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.